Arguments in favour of remdesivir for treating SARS-CoV-2 infections - Aix-Marseille Université Access content directly
Journal Articles International Journal of Antimicrobial Agents Year : 2020

Dates and versions

hal-02509378 , version 1 (16-03-2020)

Identifiers

Cite

Wen-Chien Ko, Jean-Marc Rolain, Nan-Yao Lee, Po-Lin Chen, Ching-Tai Huang, et al.. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. International Journal of Antimicrobial Agents, 2020, pp.105933. ⟨10.1016/j.ijantimicag.2020.105933⟩. ⟨hal-02509378⟩

Collections

CNRS UNIV-AMU
30 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More